Timothy Hagerty
Timothy Hagerty is scientist at Pfizer Global Research and Development Global Biologics, Bioprocess R&D
Articles
The Development and Application of a Monoclonal Antibody Purification Platform
Paul Johnson;Judy Glynn;Kristin Thomas;Natarajan Ramasubramanyan, PhD;Paul Mensah, PhD;Timothy Hagerty;Gopinath Annathur;Timothy Pabst, PhD
October 2nd 2009A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
The Development and Application of a Monoclonal Antibody Purification Platform
Paul Johnson;Judy Glynn;Kristin Thomas;Natarajan Ramasubramanyan, PhD;Paul Mensah, PhD;Timothy Hagerty;Gopinath Annathur;Timothy Pabst, PhD
March 2nd 2009A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Latest Updated Articles
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: December 9th 2024 | Updated: December 22nd 2024
Recap Key Industry Trends for Viral Clearance and NGS
Published: December 7th 2024 | Updated: December 22nd 2024
Enhancing Quality Through Training
Published: July 20th 2020 | Updated: December 22nd 2024
Contact BioPharm International Editors
Published: July 19th 2020 | Updated: December 22nd 2024
Editorial Information: BioPharm International Submission Guidelines and Editorial Calendars
